194 related articles for article (PubMed ID: 19671805)
1. Quantitative clinical rheumatology: why is a test for anti-CCP antibodies included in most routine care for rheumatoid arthritis while a HAQ/MDHAQ remains largely a research tool?
Pincus T; Yazici Y; Bergman MJ
J Rheumatol; 2009 Aug; 36(8):1563-4. PubMed ID: 19671805
[No Abstract] [Full Text] [Related]
2. Anti-cyclic citrullinated peptide antibody versus HAQ/MDHAQ: comparing apples and oranges?
Bykerk V
J Rheumatol; 2009 Aug; 36(8):1565-7. PubMed ID: 19671806
[No Abstract] [Full Text] [Related]
3. Does a positive anti-CCP test identify a distinct arthritis entity?
Skogh T
Arthritis Res Ther; 2005; 7(6):230-2. PubMed ID: 16277697
[TBL] [Abstract][Full Text] [Related]
4. [The role of anti-cyclic citrullinated peptide (anti-CCP) antibodies in serologic diagnosis and evaluation of disease activity in rheumatoid arthritis].
Aridoğan BC; Kaya S; Savaş S; Cetin ES; Akkuş S; Demirci M
Mikrobiyol Bul; 2008 Oct; 42(4):669-74. PubMed ID: 19149089
[TBL] [Abstract][Full Text] [Related]
5. Anti-CCP antibodies as an aid to prioritization of patients referred to the rheumatology clinic.
Madan A; Belshaw R; Grennan D
QJM; 2007 Nov; 100(11):737-8. PubMed ID: 17951317
[No Abstract] [Full Text] [Related]
6. Diagnostic value of anticyclic citrullinated peptide antibody in rheumatoid arthritis.
Jansen TL; Bruyn GA
J Rheumatol; 2004 May; 31(5):1012-3; author reply 1013. PubMed ID: 15124273
[No Abstract] [Full Text] [Related]
7. Rheumatoid factor and anti-CCP autoantibodies in rheumatoid arthritis: a review.
Lee AN; Beck CE; Hall M
Clin Lab Sci; 2008; 21(1):15-8. PubMed ID: 18335856
[TBL] [Abstract][Full Text] [Related]
8. Anti-cyclic citrullinated peptide antibodies distinguish hepatitis B virus (HBV)-associated arthropathy from concomitant rheumatoid arthritis in patients with chronic HBV infection.
Lim MK; Sheen DH; Lee YJ; Mun YR; Park M; Shim SC
J Rheumatol; 2009 Apr; 36(4):712-6. PubMed ID: 19286846
[TBL] [Abstract][Full Text] [Related]
9. Time to score quantitative rheumatoid arthritis measures: 28-Joint Count, Disease Activity Score, Health Assessment Questionnaire (HAQ), Multidimensional HAQ (MDHAQ), and Routine Assessment of Patient Index Data (RAPID) scores.
Yazici Y; Bergman M; Pincus T
J Rheumatol; 2008 Apr; 35(4):603-9. PubMed ID: 18322993
[TBL] [Abstract][Full Text] [Related]
10. Quantitative clinical rheumatology: "keep it simple, stupid": MDHAQ function, pain, global, and RAPID3 quantitative scores to improve and document the quality of rheumatologic care.
Pincus T; Sokka T
J Rheumatol; 2009 Jun; 36(6):1099-100. PubMed ID: 19509086
[No Abstract] [Full Text] [Related]
11. Value of anti-modified citrullinated vimentin and third-generation anti-cyclic citrullinated peptide compared with second-generation anti-cyclic citrullinated peptide and rheumatoid factor in predicting disease outcome in undifferentiated arthritis and rheumatoid arthritis.
van der Linden MP; van der Woude D; Ioan-Facsinay A; Levarht EW; Stoeken-Rijsbergen G; Huizinga TW; Toes RE; van der Helm-van Mil AH
Arthritis Rheum; 2009 Aug; 60(8):2232-41. PubMed ID: 19644872
[TBL] [Abstract][Full Text] [Related]
12. Determination of anti-CCP antibodies in patients with suspected rheumatoid arthritis: does it help to predict the diagnosis before referral to a rheumatologist?
Gao IK; Haas-Wöhrle A; Mueller KG; Lorenz HM; Fiehn C
Ann Rheum Dis; 2005 Oct; 64(10):1516-7. PubMed ID: 16162906
[No Abstract] [Full Text] [Related]
13. Mannose-binding lectin gene polymorphisms are associated with disease activity and physical disability in untreated, anti-cyclic citrullinated peptide-positive patients with early rheumatoid arthritis.
Jacobsen S; Garred P; Madsen HO; Heegaard NH; Hetland ML; Stengaard-Pedersen K; Junker P; Lottenburger T; Ellingsen T; Smedegaard Andersen L; Hansen I; Skjødt H; Pedersen JK; Lauridsen UB; Svendsen AJ; Tarp U; Pødenphant J; Lindegaard H; Vestergaard A; Østergaard M; Hørslev-Petersen K
J Rheumatol; 2009 Apr; 36(4):731-5. PubMed ID: 19273450
[TBL] [Abstract][Full Text] [Related]
14. Anti-CCP Antibody, a Marker for the Early Detection of Rheumatoid Arthritis.
van Venrooij WJ; van Beers JJ; Pruijn GJ
Ann N Y Acad Sci; 2008 Nov; 1143():268-85. PubMed ID: 19076355
[TBL] [Abstract][Full Text] [Related]
15. The detecting and clinical value of anti-cyclic citrullinated peptide antibodies in patients with systemic lupus erythematosus.
Qing YF; Zhang QB; Zhou JG; Yuan GH; Wei J; Xing Y; Liu JP; Jiang L; Chen JP
Lupus; 2009 Jul; 18(8):713-7. PubMed ID: 19502267
[TBL] [Abstract][Full Text] [Related]
16. Are anti-cyclic citrullinated peptide antibodies pathogenic in rheumatoid arthritis?
Holers VM
Nat Clin Pract Rheumatol; 2006 Aug; 2(8):400-1. PubMed ID: 16932728
[No Abstract] [Full Text] [Related]
17. Antibodies to cyclic citrullinated peptides in psoriatic arthritis: do classification criteria affect study results?
Marchesoni A; Lurati A; Desiati F; Rossi V; Battafarano N
J Rheumatol; 2006 Feb; 33(2):435; author reply 436-7. PubMed ID: 16465678
[No Abstract] [Full Text] [Related]
18. Use and significance of anti-CCP autoantibodies in rheumatoid arthritis.
Zendman AJ; van Venrooij WJ; Pruijn GJ
Rheumatology (Oxford); 2006 Jan; 45(1):20-5. PubMed ID: 16188946
[No Abstract] [Full Text] [Related]
19. A practical guide to scoring a Multi-Dimensional Health Assessment Questionnaire (MDHAQ) and Routine Assessment of Patient Index Data (RAPID) scores in 10-20 seconds for use in standard clinical care, without rulers, calculators, websites or computers.
Pincus T; Yazici Y; Bergman M
Best Pract Res Clin Rheumatol; 2007 Aug; 21(4):755-87. PubMed ID: 17678834
[TBL] [Abstract][Full Text] [Related]
20. Anti-cyclic citrullinated peptide in preclinical rheumatoid arthritis. Food for thought.
Ménard HA
J Rheumatol; 2009 Apr; 36(4):663-4. PubMed ID: 19342718
[No Abstract] [Full Text] [Related]
[Next] [New Search]
